OTCMKTS:VRSEF Verisante Technology (VRSEF) Stock Price, News & Analysis $0.01 +0.01 (+354.55%) As of 01:35 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Verisante Technology Stock (OTCMKTS:VRSEF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Verisante Technology alerts:Sign Up Key Stats Today's Range$0.01▼$0.0150-Day Range$0.0022▼$0.0152-Week Range$0.0021▼$0.01Volume500 shsAverage Volume3,571 shsMarket Capitalization$439.40 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Verisante Technology Inc. is a Canada-based medical device company focused on the development and commercialization of non-invasive cancer detection systems. The firm’s flagship offering, the Verisante Aurora, employs Raman spectroscopy and digital imaging to analyze tissue at the point of care, aiming to differentiate malignant lesions from benign skin abnormalities. By integrating optical spectroscopy with advanced data algorithms, Verisante seeks to provide clinicians with real-time diagnostic support for early-stage melanoma, basal cell carcinoma and squamous cell carcinoma. In addition to its dermatology application, Verisante has extended its technology platform toward pulmonary oncology, exploring handheld spectroscopic devices to assist in the detection of early lung cancer during bronchoscopy procedures. The company’s research and development efforts have been supported through collaborations with academic institutions and clinical centers in North America and Europe, where Aurora prototypes have undergone pilot testing in hospital and outpatient settings. Headquartered in Vancouver, British Columbia, Verisante maintains operations and regulatory support teams in Europe to address CE-mark requirements and engage local distributors. The company’s management team combines expertise in medical optics, regulatory affairs and commercialization strategy, positioning Verisante to address the global need for rapid, minimally invasive cancer screening tools.AI Generated. May Contain Errors. Read More Receive VRSEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verisante Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VRSEF Stock News HeadlinesVER.H:CA AnalysisApril 10, 2025 | seekingalpha.comClosing Bell: Verisante Technology Inc down on Friday (VER-H)August 7, 2024 | theglobeandmail.comAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."September 18 at 2:00 AM | Brownstone Research (Ad)Closing Bell: Verisante Technology Inc up on Tuesday (VER-H)July 24, 2024 | theglobeandmail.comVerisante: Q4 Earnings SnapshotMarch 29, 2024 | sfgate.comVerisante Technology, Inc. Announces 2023 AGM ResultsDecember 21, 2023 | finance.yahoo.comVerisante Technology, Inc. Announces Exchange Approval for Shares for Debt TransactionOctober 5, 2023 | finance.yahoo.comVerisante Technology Inc. Announces Shares for Debt AgreementsSeptember 8, 2023 | finance.yahoo.comSee More Headlines VRSEF Stock Analysis - Frequently Asked Questions How have VRSEF shares performed this year? Verisante Technology's stock was trading at $0.0050 at the beginning of 2025. Since then, VRSEF stock has increased by 100.0% and is now trading at $0.01. When did Verisante Technology's stock split? Verisante Technology's stock reverse split on Thursday, June 23rd 2022.The 1-10 reverse split was announced on Thursday, June 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Verisante Technology? Shares of VRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:VRSEF CIKN/A Webwww.verisante.com Phone(604) 716-5133Fax604-605-0508EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$80 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,204.19% Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.17 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares43,940,000Free FloatN/AMarket Cap$439.40 thousand OptionableNot Optionable Beta19.42 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:VRSEF) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verisante Technology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verisante Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.